Optinose to Present at the Needham Virtual Healthcare Conference

Rhea-AI Summary

Optinose (NASDAQ:OPTN) has announced that its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 17, 2023, at 3:45 p.m. ET. Interested parties can tune in to the live webcast through the Investors page of the Optinose website. A replay of the presentation will be accessible for 30 days post-event.

Optinose specializes in providing treatments for patients attended to by ear, nose, and throat (ENT) and allergy specialists. The company aims to address specific needs within this domain. For further details, visit www.optinose.com or follow them on social media platforms such as Twitter and LinkedIn.

News Market Reaction – OPTN

-0.51%

-0.51% Session move

In the trading session that priced this news, OPTN declined 0.51%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

YARDLEY, Pa., April 12, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 17, 2023 at 3:45 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531

FAQ

When is Optinose presenting at the Needham Virtual Healthcare Conference?

Optinose will present on April 17, 2023, at 3:45 p.m. ET.

How can I listen to Optinose's presentation?

You can listen to the live webcast on the Investors page of the Optinose website.

Will there be a replay of the Optinose presentation?

Yes, a replay of the presentation will be available for 30 days after the event.

What is Optinose's focus in the pharmaceutical industry?

Optinose focuses on treating patients cared for by ear, nose, and throat (ENT) and allergy specialists.

Where can I find more information about Optinose?

More information can be found on their website at www.optinose.com.